MedTrace Logo

Exploratory Clinical Study for Techniques Associated With the Fluid Accommodating IOL

NCT04330001 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2023-05-06

No results posted yet for this study

Summary

The purpose of this clinical study is to assess the repeatability of objective refraction using auto refraction on subjects bilaterally implanted (implanted in both eyes) with the Fluid Accommodating IOL (FAIOL).

Conditions

Interventions

DEVICE

Alcon Fluid Accommodating Intraocular Lens

Intraocular lens intended to treat presbyopia by dynamically adjusting power, resulting in a continuous range of vision from distance to near.

OTHER

Top Con Autorefractor

Device intended to automatically determine the focusing characteristics of the eye

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Clinical Operation Lead CDMA Surgical · Alcon Research

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-28
Primary Completion
2022-06-08
Completion
2023-05-03

Countries

  • El Salvador
  • Panama

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04330001 on ClinicalTrials.gov